SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-04-000700
Filing Date
2004-03-12
Accepted
2004-03-12 16:58:51
Documents
4
Period of Report
2004-03-12
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f97252e8vk.htm 8-K 10180
3 EXHIBIT 10.44 f97252exv10w44.txt EX-10.44 139592
4 EXHIBIT 10.45 f97252exv10w45.txt EX-10.45 35669
5 EXHIBIT 99.1 f97252exv99w1.txt EX-99.1 3180
  Complete submission text file 0000891618-04-000700.txt   190537
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 04666768
SIC: 2833 Medicinal Chemicals & Botanical Products